Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin-and dopamine-mediated behaviour

Abstract

When rats are given a series of electroconvulsive shocks (ECSs) over several days, they display enhanced behavioural responses to both serotonin- and dopamine-receptor agonists 1–3. Because these changes are seen when the ECS is given in ways closely mimicking the clinical administration of electroconvulsive therapy (ECT), it has been suggested that the changes in post-synaptic monoamine function may be involved in the antide-pressant mechanisms of ECT4,5. Ligand-binding studies have excluded the possibility that ECS alters the characteristics of either the serotonin or dopamine receptor6–8; ECS may therefore be acting on neuronal systems which modulate monoamine neurotransmission. As repeated ECS has recently been reported to decrease both noradrenaline (NA)-sensitive adenylate cyclase9 and β-adrenoreceptor binding8,10,11, we have examined here whether changes in NA function are related to the effects of ECS on the serotonin- and dopamine-mediated behaviours. We demonstrate that although selective depletion of NA does not alter the drug-induced serotonin- and dopamine-mediated responses, it abolishes the ECS-induced enhancement of these behaviours.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Modigh, K. J. neural Transmission 36, 19–32 (1975).

    Article  CAS  Google Scholar 

  2. Evans, J. P. M., Grahame-Smith, D. G., Green, A. R. & Tordoff, A. F. C. Br. J. Pharmac. 56, 193–199 (1976).

    Article  CAS  Google Scholar 

  3. Green, A. R., Heal, D. J. & Grahame-Smith, D. G. Psychopharmacology 52, 195–200 (1977).

    Article  CAS  Google Scholar 

  4. Costain, D. W., Green, A. R. & Grahame-Smith, D. G. Psychoparmacology 61, 167–170 (1979).

    Article  CAS  Google Scholar 

  5. Grahame-Smith, D. G., Green, A. R. & Costain, D. W. Lancet i, 254–257 (1978).

    Article  Google Scholar 

  6. Cross, A. J. et al. Br. J. pharmac. 66, 111P (1979).

    CAS  Google Scholar 

  7. Atterwill, C. K. & Prince, A. K. 11th int. Meet. int. Soc. Neurochem., Jerusalem (1979).

  8. Bergstrom, D. A. & Kellar, K. J. Nature 278, 464–466 (1979).

    Article  ADS  CAS  Google Scholar 

  9. Vetulani, J., Schwartz, R. J., Dingell, J. V. & Sulser, F. Naunyn-Schmiedebergs Archs Pharmak. 293, 109–114 (1976).

    Article  CAS  Google Scholar 

  10. Pandey, G. N., Heinze, W. J., Brown, B. D. & Davis, J. M. Nature 280, 234–235 (1979).

    Article  ADS  CAS  Google Scholar 

  11. Deakin, J. F. W., Owen, F. & Poulter, M. Neurosci. Lett. (in the press).

  12. Curzon, G. & Green, A. R. Br. J. Pharmac. 39, 653–655 (1970).

    Article  CAS  Google Scholar 

  13. Chang, C. C. Int. J. Neuropharmac. 3, 645–649 (1964).

    Article  Google Scholar 

  14. Green, A. R., Youdim, M. B. H. & Grahame-Smith, D. G. Neuropharmacology 15, 173–179 (1976).

    Article  CAS  Google Scholar 

  15. Green, A. R. & Grahame-Smith, D. G. Neuropharmacology 13, 949–959 (1974).

    Article  CAS  Google Scholar 

  16. Mussachio, J. M., Julou, L., Kety, S. S. & Glowinski, J. Proc. natn. Acad. Sci. U.S.A. 63, 1117–1119 (1969).

    Article  ADS  Google Scholar 

  17. Modigh, K. Psychopharmacology 49, 179–185 (1976).

    Article  CAS  Google Scholar 

  18. Kety, S. S., Javoy, F., Therry, A. M., Julou, L. & Glowinski, J. Proc. natn. Acad. Sci. U.S.A. 58, 1249–1254 (1967).

    Article  ADS  CAS  Google Scholar 

  19. Modigh, K. in Neuropsychopharmacology (eds Saletu, B. & Hollister, L.) (Pergamon, Oxford, in the press).

  20. Hendley, E. D. Psychopharmac. Commun. 2, 17–25 (1976).

    CAS  Google Scholar 

  21. van Praag, H. M. Depression and Schizophrenia (Spectrum, Flushing, 1976).

    Google Scholar 

  22. Green, A. R., Costain, D. W. & Deakin, J. F. W. Neuropharmacology (in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Green, A., Deakin, J. Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin-and dopamine-mediated behaviour. Nature 285, 232–233 (1980). https://doi.org/10.1038/285232a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/285232a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing